Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction
Recruiting
Phase 4
Interventional Study
Anterior Cruciate Ligament Tear
Anterior Cruciate Ligament Injuries
Anterior Cruciate Ligament Rupture
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 40
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 84 (estimated)
- Sponsor
- The Methodist Hospital Research Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to determine if intraosseous (IO) morphine decreases pain and post-operative opioid use in patients undergoing anterior cruciate ligament (ACL) reconstruction.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients of the IRB approved surgeon(s) undergoing ACL reconstruction with bone-to-bone (BTB) autograft
* Patients aged between 18-40 years old at the time of surgery
Exclusion Criteria:
* Patients undergoing ACL reconstruction with any other type of autograft or allograft o…
Contacts